We are monitoring the impact of COVID-19 on MEA Orthobiologics Market Get in touch with us for detailed analysis Know More
Pulished Date April, 2021
ID: 7133
Share on
Share on

Middle East & Africa Orthobiologics Market Research Report – Segmented By Product, Application, End Users Country (KSA, UAE, Israel, rest of GCC countries, South Africa, Ethiopia, Kenya, Egypt, Sudan, rest of MEA) - Industry Analysis on Size, Share, Trends, COVID-19 Impact & Growth Forecast (2021 to 2026)

Pulished: April, 2021
ID: 7133
Pages: 145

MEA Orthobiologics Market Size (2021 to 2026)

The size of the Orthobiologics Market in the Middle East & Africa was worth USD 416.12 million in 2021 and estimated to be growing at a CAGR of 4.03%, to reach USD 507.00 million by 2026. 

Regenerative cellular therapies are another name for orthobiologics. Orthobiologics products contain or produce growth factors to aid tissue repair, reduce pain, and help restore normal function. There are many distinct forms of orthobiologics on the market, each with its own mode of action. Autologous stem cells are produced from the patient's body and divide under the correct conditions to form progenitor cells. Orthobiologics are mostly used to aid in the speedier healing of injuries.

The rise in the geriatric population, which is more susceptible to diseases such as osteoarthritis and others, is fueling the expansion of the orthobiologics market in the MEA region. Other factors projected to drive the market growth include increased awareness of orthobiologics and increased demand for improved therapy. In addition, the rise in obesity and the number of sports and road accidents are all contributing to the expansion of the orthobiologics industry in the MEA.

The further expansion in the orthobiologics sector is mostly due to increased demand and rapid adoption of newly developed products such as Medtronic's Infuse, a bone morphogenetic protein, and others. In addition, the market growth is also likely to be accelerated as the prevalence of the disease grows and the introduction of innovative products.

The MEA orthobiologics market is forecasted to be hampered by difficult syncretization procedures, industrial rules, and high production costs. In addition, high costs and poor reimbursements for orthobiologics goods and procedures are other important issues limiting the market's growth. One of the other major obstacles to the MEA orthobiologics market's growth is the high cost of orthobiologics treatments and products.

This research report on the MEA orthobiologics market has been segmented & sub-segmented into the following categories:

By Product: 

  • Viscosupplementation
  • Demineralized Bone Matrices
  • Synthetic Orthobiologics
  • Bone Morphogenic Protein
  • Allografts
  • Plasma-Rich Protein
  • Bone Marrow Aspirate Concentrate

By Application: 

  • Osteoarthritis and Degenerative Arthritis
  • Spinal Fusion
  • Fracture Recovery
  • Soft Tissue Injuries
  • Maxillofacial & Dental Applications

By End Users: 

  • Hospitals
  • Orthopedic Clinics
  • Ambulatory Care Centres
  • Research and Academic Institutes
  • Dental Clinics & Facilities

By Country: 

  • KSA
  • UAE
  • Israel
  • rest of GCC countries
  • South Africa
  • Ethiopia
  • Kenya
  • Egypt
  • Sudan
  • rest of MEA

Geographically, due to increased demand for treatment of sports injuries and an increase in government activities to raise awareness of orthobiologics, the Middle East and Africa are likely to have significant market potential in the foreseeable future. The novel treatments are projected to effectively lower surgical problems, propelling the orthobiologics market forward during the forecast period. The increased incidence of orthopedics disease and musculoskeletal disorders are important driving factors in the MEA orthobiologics market. As the disease's prevalence rises, and so will the development of innovative solutions in this region, market demand is expected to accelerate.

Furthermore, growing technological breakthroughs in biomaterials utilized in orthobiologics are projected to boost market demand during the forecast period, according to MEA. The introduction of recombinant biologic medicines, changes in graft designs, cultured tissue scaffolds, and stem cell therapy are all examples of these. These advancements come with advantages, including shorter operating times, improved biocompatibility, and smaller incisions.

During the forecast period, the market players are expected to benefit from the strong development potential in this region and an increase in demand for sophisticated therapy. Hospitals account for a sizable portion of the end-user market in this region. The key driver giving the most important shares to this segment is the increasing acceptance of ortho biological products in a wide range of spinal and reconstructive procedures conducted in hospitals. This market is expected to develop due to specialized patient care and the simple availability of a large range of orthobiologics in hospitals.

KEY MARKET PLAYERS:

Medtronic, DePuy Synthes, Zimmer Biomet, Bioventus, Stryker, Harvest Technologies, Globus, Orthofix International, RTI Surgical, K2M Group, and Kuros Biosciences are some of the key players in the MEA orthobiologics market.

1. Introduction                                 

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods                          

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                               

                2.2 Research Phases                      

                                2.2.1 Secondary Research           

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling      

                                2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline                          

3. Overview                                       

                3.1 Executive Summary                

                3.2 Key Inferences                         

                3.3 Epidemology                              

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                    

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market                              

5. Market Segmentation                                              

                5.1 Product                        

                                5.1.1 Viscosupplementation       

                                5.1.2 Products  

                                5.1.3 Demineralized Bone Matrices         

                                5.1.4 Synthetic Orthobiologics   

                                5.1.5 Bone Morphogenic Protein             

                                5.1.6 Allografts 

                                5.1.7 Plasma-Rich Protein            

                                5.1.8 Bone Marrow Aspirate Concentrate            

                                5.1.9  Y-o-Y Growth Analysis, By Product              

                                5.1.10  Market Attractiveness Analysis, By Product          

                                5.1.11  Market Share Analysis, By Product            

                5.2 Application                 

                                5.2.1 Osteoarthritis and Degenerative Arthritis  

                                5.2.2 Spinal Fusion          

                                5.2.3 Fracture Recovery               

                                5.2.4 Soft Tissue Injuries              

                                5.2.5 Maxillofacial & Dental Applications               

                                5.2.6 Y-o-Y Growth Analysis, By Application         

                                5.2.7 Market Attractiveness Analysis, By Application       

                                5.2.8 Market Share Analysis, By Application        

                5.3 End Users                    

                                5.3.1 Hospitals  

                                5.3.2 Orthopaedic Clinics              

                                5.3.3 Ambulatory Care Centres 

                                5.3.4 Research and Academic Institutes                

                                5.3.5 Dental Clinics & Facilities   

                                5.3.6 Y-o-Y Growth Analysis, By End Users           

                                5.3.7  Market Attractiveness Analysis, By End Users        

                                5.3.8  Market Share Analysis, By End Users          

6. Geographical Analysis                                              

                6.1 Introduction                               

                                6.1.1 Regional Trends    

                                6.1.2 Impact Analysis     

                                6.1.3 Y-o-Y Growth Analysis        

                                                6.1.3.1 By Product

                                                6.1.3.2 By Application

                                                6.1.3.3 By End Users

                                6.1.4  Market Attractiveness Analysis     

                                                6.1.4.1 By Product

                                                6.1.4.2 By Application

                                                6.1.4.3 By End Users

                                6.1.5  Market Share Analysis      

                                                6.1.5.1 By Product

                                                6.1.5.2 By Application

                                                6.1.5.3 By End Users

                6.2 Middle-East                                

                6.3 Africa                            

7. Strategic Analysis                                       

                7.1 PESTLE analysis                         

                                7.1.1 Political     

                                7.1.2 Economic 

                                7.1.3 Social         

                                7.1.4 Technological         

                                7.1.5 Legal          

                                7.1.6 Environmental       

                7.2 Porter’s Five analysis                              

                                7.2.1 Bargaining Power of Suppliers        

                                7.2.2 Bargaining Power of Consumers    

                                7.2.3 Threat of New Entrants     

                                7.2.4 Threat of Substitute Products and Services              

                                7.2.5 Competitive Rivalry within the Industry     

8. Market Leaders' Analysis                                        

                8.1 Medtronic                   

                                8.1.1 Overview 

                                8.1.2 Product Analysis   

                                8.1.3 Financial analysis  

                                8.1.4 Recent Developments       

                                8.1.5 SWOT analysis       

                                8.1.6 Analyst View          

                8.2 DePuy Synthes                         

                8.3 Zimmer Biomet                         

                8.4 Bioventus                    

                8.5 Stryker                         

                8.6 Harvest Technologies                             

                8.7 Globus                          

                8.8 Orthofix International                            

                8.9 RTI Surgical                 

                8.10 K2M Group                              

                8.11 Kuros Biosciences                  

9. Competitive Landscape                                           

                9.1 Market share analysis                            

                9.2 Merger and Acquisition Analysis                       

                9.3 Agreements, collaborations and Joint Ventures                         

                9.4 New Product Launches                         

10. Market Outlook and Investment Opportunities                                         

Appendix                                           

                a) List of Tables                

                b) List of Figures                              

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms By Product and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis, and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. Middle East and Africa Orthobiologics Market, By Product, From 2021 to 2026 (USD Million)
  2. Middle East and Africa Viscosupplementation Market, By Region, From 2021 to 2026 (USD Million)
  3. Middle East and Africa Products Market, By Region, From 2021 to 2026 (USD Million)
  4. Middle East and Africa DBM Market, By Region, From 2021 to 2026 (USD Million)
  5. Middle East and Africa Synthetic Orthobiologics Market, By Region, From 2021 to 2026 (USD Million)
  6. Middle East and Africa BMP Market, By Region, From 2021 to 2026 (USD Million)
  7. Middle East and Africa Allografts Market, By Region, From 2021 to 2026 (USD Million)
  8. Middle East and Africa PRP Market, By Region, From 2021 to 2026 (USD Million)
  9. Middle East and Africa BMAC Market, By Region, From 2021 to 2026 (USD Million)
  10. Middle East and Africa Orthobiologics Market, By Application, From 2021 to 2026 (USD Million)
  11. Middle East and Africa Osteoarthritis and Degenerative Arthritis Market, By Region, From 2021 to 2026 (USD Million)
  12. Middle East and Africa Spinal Fusion Market, By Region, From 2021 to 2026 (USD Million)
  13. Middle East and Africa Fracture Recovery Market, By Region, From 2021 to 2026 (USD Million)
  14. Middle East and Africa Soft Tissue Injuries Market, By Region, From 2021 to 2026 (USD Million)
  15. Middle East and Africa Maxillofacial & Dental Applications Market, By Region, From 2021 to 2026 (USD Million)
  16. Middle East and Africa Orthobiologics Market, By End Users, From 2021 to 2026 (USD Million)
  17. Middle East and Africa Hospitals Market, By Region, From 2021 to 2026 (USD Million)
  18. Middle East and Africa Orthopaedic Clinics Market, By Region, From 2021 to 2026 (USD Million)
  19. Middle East and Africa Ambulatory Care Centres Market, By Region, From 2021 to 2026 (USD Million)
  20. Middle East and Africa Research and Academic Institutes Market, By Region, From 2021 to 2026 (USD Million)
  21. Middle East and Africa Dental Clinics & Facilities Market, By Region, From 2021 to 2026 (USD Million)
  22. Middle East Orthobiologics Market, By Product, From 2021 to 2026 (USD Million)
  23. Middle East Orthobiologics Market, By Application, From 2021 to 2026 (USD Million)
  24. Middle East Orthobiologics Market, By End Users, From 2021 to 2026 (USD Million)
  25. Africa Orthobiologics Market, By Product, From 2021 to 2026 (USD Million)
  26. Africa Orthobiologics Market, By Application, From 2021 to 2026 (USD Million)
  27. Africa Orthobiologics Market, By End Users, From 2021 to 2026 (USD Million)

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 2875

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample